Patents Assigned to The United States of America, as represented by the Secretary, Departnemt of Health and Human Services
  • Interleukin-4 receptor-binding fusion proteins and uses thereof
    Patent number: 11084856
    Abstract: The present invention relates to interleukin-4 receptor binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 receptor binding protein moiety joined to a pro-apoptotic Bcl-2 family member protein moiety.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: August 10, 2021
    Assignees: Medicenna Therapeutics, Inc., The United States of America, as represented by the Secretary, Departnemt of Health and Human Services
    Inventors: Fahar Merchant, Raj K. Puri, Bharatkumar H. Joshi